Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities
To address the continued rise of multi-drug-resistant microorganisms, the development of novel drugs with new modes of action is urgently required. While humans biosynthesize the essential isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) via the established m...
Main Authors: | Talea Knak, Mona A. Abdullaziz, Stefan Höfmann, Leandro A. Alves Avelar, Saskia Klein, Matthew Martin, Markus Fischer, Nobutada Tanaka, Thomas Kurz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/12/1553 |
Similar Items
-
Inhibitory Effects of Fosmidomycin Against Babesia microti in vitro
by: Sen Wang, et al.
Published: (2020-04-01) -
Predicting Drug Resistance Using Deep Mutational Scanning
by: Gur Pines, et al.
Published: (2020-05-01) -
The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in <named-content content-type="genus-species">Plasmodium falciparum</named-content>
by: Laure Dumont, et al.
Published: (2019-12-01) -
α,α-Difluorophosphonohydroxamic Acid Derivatives among the Best Antibacterial Fosmidomycin Analogues
by: Aurore Dreneau, et al.
Published: (2021-08-01) -
Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum
by: María B Cassera, et al.
Published: (2007-06-01)